Abstract:Cisplatin is still one of the first-line drugs for chemotherapy of head and neck squamous cell carcinoma (HNSCC) and shows a survival advantage for HNSCC. However, a substantial proportion of HNSCC eventually becomes resistance to cisplatin and the underlying mechanisms remain to be fully understood. Yin Yang 1 (YY1) is a multifunctional protein regulating both gene transcription and protein modifications and also plays a role in chemotherapy resistance. Here, we reported that knockdown of YY1 by lentivirus-mediated short hairpin RNA or tetracycline-inducible short hairpin RNA enhanced cisplatin-induced apoptosis and inhibition of cell proliferation, migration and invasion in the HNSCC cell lines, and inhibition of the xenograft tumor growth. The underlying mechanisms were revealed that knockdown of YY1 downregulated both S473 and T308 phosphorylation of AKT (protein kinase B), which was mainly responsible for cisplatin resistance, whereas overexpression of YY1 upregulated both S473 and T308 phosphorylation. Cisplatin upregulated YY1 mRNA and protein expression and both S473 and T308 phosphorylation of AKT. In the presence of cisplatin, knockdown of YY1 not only blocked cisplatin-induced increase in S473 and T308 phosphorylation of AKT, but still downregulated T308 phosphorylation. Moreover, protein phosphatase 2A (PP2A) antagonist, okadaic acid, upregulated T308, but not S473, phosphorylation, and simultaneously abolished YY1 knockdown-mediated enhancement of cisplatin-induced inhibition of cell proliferation. In addition, knockdown of YY1 promoted PP2A activity through upregulating mRNA and protein expressions of PP2A catalytic subunit alpha (PPP2CA) through the binding of YY1 in the promoter of PPP2CA. Conversely, activating PP2A by forskolin also promoted YY1 degradation and subsequently inhibited T308 phosphorylation. These results suggested that knockdown of YY1 enhanced anticancer effects of cisplatin through PP2A mediating T308 dephosphorylation of AKT, and that targeting YY1 or PP2A would enhance the efficiency of cisplatin chemotherapy in treatment of HNSCC.

YC-1 Induces G0/G1phase Arrest and Mitochondria-Dependent Apoptosis in Cisplatin-Resistant Human Oral Cancer CAR Cells

Myricetin Inhibits Proliferation of Cisplatin-Resistant Cancer Cells Through a P53-Dependent Apoptotic Pathway

YC-1 induced DNA damage and Chk2-mediated E2F1 activation leading to breast cancer cell apoptosis

YC-1 Induces Apoptosis of Human Renal Carcinoma A498 Cells in Vitro and in Vivo Through Activating JNK Pathway

YC-1 Suppresses Constitutive Nuclear Factor-Κb Activation and Induces Apoptosis in Human Prostate Cancer Cells

Anticancer Mechanisms of YC-1 in Human Lung Cancer Cell Line, NCI-H226.

YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole] Exhibits a Novel Antiproliferative Effect and Arrests the Cell Cycle in G0-G1 in Human Hepatocellular Carcinoma Cells.

Proteomic Approach to Studying the Cytotoxicity of YC‐1 on U937 Leukemia Cells and Antileukemia Activity in Orthotopic Model of Leukemia Mice

YC‐1 Inhibits Proliferation of Breast Cancer Cells by Down‐regulating EZH2 Expression Via Activation of C‐cbl and ERK

Effects of YC-1 on Hypoxia-Inducible Factor 1-Driven Transcription Activity, Cell Proliferative Vitality, and Apoptosis in Hypoxic Human Pancreatic Cancer Cells

Effect of YC-1 on Improving Hypoxia and Radiosensitizing Human Lung Adenocarcinoma Cellsin Vitro

Depletion of 4E-Bp1 and Regulation of Autophagy Lead to Yxm110-Induced Anticancer Effects

In vitro Reguation of YC-1 on the Chemotherapy Sensitivity of Ovarian Cancer

Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling.

Effects of YC-1 on Hypoxia-Inducible Factor 1 Alpha in Hypoxic Human Bladder Transitional Carcinoma Cell Line T24 Cells.

YC-1 Potentiates the Antitumor Activity of Gefitinib by Inhibiting HIF-1α and Promoting the Endocytic Trafficking and Degradation of EGFR in Gefitinib-Resistant Non-Small-cell Lung Cancer Cells

Resveratrol-induced Autophagy and Apoptosis in Cisplatin-Resistant Human Oral Cancer CAR Cells: A Key Role of AMPK and Akt/mTOR Signaling.

Effects of YC-1 Targeting Hypoxia-Inducible Factor 1 Alpha in Oesophageal Squamous Carcinoma Cell Line Eca109 Cells.

Inhibition of Cyclin D1 Expression by Cyclin D1 Shrnas in Human Oral Squamous Cell Carcinoma Cells is Associated with Increased Cisplatin Chemosensitivity.

Knockdown of Yin Yang 1 Enhances Anticancer Effects of Cisplatin Through Protein Phosphatase 2A-Mediated T308 Dephosphorylation of AKT

Potential Effects of Allyl Isothiocyanate on Inhibiting Cellular Proliferation and Inducing Apoptotic Pathway in Human Cisplatin-Resistant Oral Cancer Cells.